Neurogenic bowel treatments and continence outcomes in children and adults with myelomeningocele.

ABSTRACT:

Purpose

Neurogenic bowel dysfunction (NBD) is a common comorbidity of myelomeningocele (MMC), the most common and severe form of spina bifida. The National Spina Bifida Patient Registry (NSBPR) is a research collaboration between the CDC and Spina Bifida Clinics. Fecal continence (continence) outcomes for common treatment modalities for NBD have not been described in a large sample of individuals with MMC. NSBPR patients with MMC and NBD were studied to determine variation in continence status and their ability to perform their treatment independently according to treatment modality and individual characteristics.

Methods

Continence was defined as < 1 episode of incontinence per month. Eleven common treatments were evaluated. Inclusion criteria were established diagnoses of

SUBMITTER: Kelly MS 

PROVIDER: S-EPMC8776357 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature